Indiċi 
 Preċedenti 
 Li jmiss 
 Test sħiħ 
Proċedura : 2018/2775(RSP)
Ċiklu ta' ħajja waqt sessjoni
Ċiklu relatat mad-dokument : B8-0071/2019

Testi mressqa :

B8-0071/2019

Dibattiti :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Votazzjonijiet :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Spjegazzjoni tal-votazzjoni

Testi adottati :

P8_TA(2019)0113

Dibattiti
L-Erbgħa, 13 ta' Frar 2019 - Strasburgu Edizzjoni riveduta

16.11. L-użu tal-kannabis għal skopijiet mediċinali (B8-0071/2019) (votazzjoni)
Vidjow tat-taħditiet
PV
 

- Prima della votazione sull'emendamento 11:

 
  
MPphoto
 

  Luke Ming Flanagan (GUE/NGL). – Mr President, the reason for the oral amendment is we have left two members of the cannabis family out of what should have been there. It should also include cannabis indica and cannabis ruderalis. Cannabis ruderalis has very low amounts of tetrahydrocannabinol (THC) in comparison to cannabidiol, which is what some people want here and cannabis indica has a better balance of cannabidiol with THC, so if you want to do it right, include this.

 
  
MPphoto
 

  Dubravka Šuica, on behalf of the PPE Group. – Mr President, on behalf of the PPE Group, I object to this oral amendment.

 
  
 

(L'emendamento orale non è accolto vista l'opposizione di oltre 40 deputati presenti in aula)

 
Aġġornata l-aħħar: 24 ta' Mejju 2019Avviż legali